Cargando…
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021
BACKGROUND AND OBJECTIVE: Hong Kong, like many parts of Asia, faces a high burden of hepatocellular carcinoma (HCC) caused by high endemic rates of hepatitis B virus infection. Hong Kong clinicians have developed a high level of expertise in HCC treatment across surgical, transarterial, ablative, ra...
Autores principales: | Cheung, Tan-To, Yu, Simon Chun-Ho, Chan, Stephen L., Poon, Ronnie T. P., Kwok, Philip, Lee, Ann-Shing, Tai, Anna, Tam, Derek, Cheung, Chin-Cheung, Lai, Tak-Wing, Chia, Nam-Hung, Law, Ada, Shum, Tracy, Lam, Yim-Kwan, Lau, Vince, Lee, Victor, Chong, Charing, Tang, Chung-Ngai, Yau, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282685/ https://www.ncbi.nlm.nih.gov/pubmed/37351136 http://dx.doi.org/10.21037/hbsn-21-405 |
Ejemplares similares
-
Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology
por: Ma, Wai‐Kit, et al.
Publicado: (2019) -
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions
por: Cheung, Tan-To, et al.
Publicado: (2023) -
Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology
por: Chiu, Peter K. F., et al.
Publicado: (2022) -
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan
por: Yau, Thomas, et al.
Publicado: (2022) -
Clinical Therapeutics in Hong Kong
por: Cheung, Bernard M.Y., et al.
Publicado: (2019)